CathWorks
@CathWorks
Followers
1K
Following
440
Media
569
Statuses
885
CathWorks is dedicated to partnering with physicians to improve the health of patients by transforming how cardiovascular disease is diagnosed and treated.
USA, Israel and Japan
Joined March 2019
š« The world of coronary physiology is transforming, and #TCT2024 showcased just how far weāve come! Itās clearā #TheNewEraInPhysiology is here, and itās powered by the #FFRangio System.
0
3
7
Humbled and honored to be able to share my passion for coronary physiology along with the luminaries, @MortonKern! Excited about having this innovative and disruptive technology at @MtnsideMedCtr! We are truly delivering tomorrowās care - today. @RaminMousaviMBA
@CathWorks
#TheNewEraInPhysiology is here. Donāt just take our word for it. Hear from the experts. #TCT2024 | @MortonKern | @DrAnkitKPatel | @shailsingh
1
3
9
#TheNewEraInPhysiology is here. Donāt just take our word for it. Hear from the experts. #TCT2024 | @MortonKern | @DrAnkitKPatel | @shailsingh
0
2
7
Congratulations to Dr. Kazuhiro Dan for presenting his latest data comparing #FFRangio and IVUS measurements, showing excellent correlation between the two modalities with regards to lesion length and vessel diameters. Weāre grateful to Dr. Dan for his ongoing contribution to
0
1
5
š„Behind the scenes at #TCT2024! Stay tuned for the latest @CathWorks insights and updates. #TheNewEraInPhysiology
0
1
3
My #TCT2024 highlight today was the excellent session on coronary physiology: FFRangio in PROVISION, PPG, and iFR/FFR in ORBITA-2 @TCTConference @CCAD_MHIF @PedroEPCarvalho
0
5
15
Congratulations to Dr. @DrAllenJ, Dr. Ajay Kirtane, Prof. Hitoshi Matsuo, and Dr. @wfearonmd for a fantastic #TCT2024 lunchtime symposium that was standing room only! The audience was eager to learn about how the CathWorks #FFRangio System is bringing the benefits of
0
1
4
Congratulations to Prof. Hitoshi Matsuo for his presentation on the PROVISION Study today at #TCT2024, where the theatre was standing room only. Prof. Matsuo showed that the study met its primary endpoint and revealed significant economic and resource utilization advantages for
0
1
5
Today at the #TCT2024 conference, Professor Hitoshi Matsuo from Gifu Heart Center shared results from the PROVISION Study, the first RCT of FFRangio outcomes compared to invasive wire-based FFR. The study met its primary endpoint and revealed significant economic and resource
0
1
3
We're all set at #TCT2024 and the exhibits are officially open! Come visit the CathWorks booth to experience #TheNewEraInPhysiology with a live demonstration from our talented team. Don't miss our symposium tomorrow at 12:15PM, where the expert panel will discuss how the
0
0
2
CathWorks announces key events for the annual TCT conference kicking off this weekend in Washington, DC. The CathWorks #FFRangioĀ® System will be featured in multiple scientific presentations including the first ever prospective RCT comparing an angio-based physiology tool versus
0
1
2
We are thrilled to welcome Todd Christianson to CathWorks as a Territory Manager in Wisconsin! Todd brings over 20 years of experience in interventional cardiology medical device sales, with considerable expertise in coronary physiology and intravascular imaging. He has been
0
0
2
Read how the CathWorks #FFRangio System is enhancing the way doctors at @AdventHealth detect and treat coronary artery disease, making procedures safer and less burdensome for patients. Dr. Dean Abtahi highlights, āThis is about making sure we are treating patients in the safest
0
1
2
We are thrilled to welcome Robert Miller to CathWorks as the Territory Manager for Florida! Robert brings over 20 years of experience in interventional cardiology and cardiac surgery. His passion to transform cardiovascular care, combined with his extensive industry expertise,
0
0
3
Congratulations to Dr. @DrAnkitKPatel, and the entire team at @MtnsideMedCtr for achieving the significant accomplishment of performing 100 #FFRangio cases! We're grateful for the committed partnership with such a dedicated team as we continue to transform cardiovascular disease
0
1
6
Congratulations to Dr. @SFournierMD and the entire team at CHUV -Ā Lausanne University Hospital in Switzerland for enrolling their first patient in the global ALL-RISE Study! We are grateful to partner with such a dedicated team and look forward to providing additional evidence
0
1
5